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AAlthough both theoretics
BSTRACT
1 and clinical issues are being investi-
gated in the area of biofeedback, the need for the delineation of the
potent variables is evident. Re search must be designed to separate out
the nonspecific placebo factors which are involved in biofeedback proce-
dures. The present study incorporates a 2 x 2 x 2 factorial design to
investigate the effects of two placebo variables— "expectancy of gain"
and' an apparatus placebo— on an electromyogram (EMG) feedback task.
Each of the forty-eight male undergraduate subjects had baseline
EMG frontalis levels recorded. Two baseline periods were utilized to
assess the before and after effects of the introduction of the inde-
pendent variables. Each subject then received two twelve minute EMG
feedback training sessions. The apparatus condition involved the pres-
ence or absence of additional, nonessential equipment. The expectancy
condition involved the presence or absence of positive information con-
cerning the efficacy of feedback and benefits to be gained. The depen-
dent measures included the EMG recording of the frontalis muscle poten-
tial during baseline and training sessions along with a post-session
questionnaire used to assess subject expectancy and perception of the
experimenter.
The results demonstrated a significant but paradoxical apparatus 
effect in that those subjects Who did not receive the placebo appara­
tus had significantly lower EMG levels. The importance of interpersonal
viii
relations was also indicated as subjects who perceived the experimenter 
as friendly and concerned tended to have lower EMG levels. The nonsig­
nificant expectancy effect was dfLscussed in terms of the effect of prior 
knowledge of feedback. The importance of baseline measurements was also 
discussed in terms of length of baseline periods and the use of base­
lines for covariate adjustment.
IX
CHAPTER I
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2autonomic processes as his original study dealt with the instrumental 
conditioning of the autonomic salivation response in dogs (Miller & 
Carmona, 1967). This was followed by other studies involving the 
instrumental conditioning of heart rate changes in curarized rats 
(Miller & DiCara, 1967), urine formation in rats (Miller & DiCara,
1968), and intestinal and cardiac response in rats (Miller & Banuazizi, 
1968).
Studies with human subjects have demonstrated that instrumental 
conditioning is possible with a variety of somatic, visceral and nervous 
system responses including individual motor units (Basmajian, 1962), 
heart rate (Bergman & Johnson, 1972; Blanchard & Young, 1973; Engel & 
Chism, 1967; Engel & Hansen, 1966) systolic blood pressure (Shapiro, 
Tursky, Gershon & Stern, 1969; Shapiro, Tursky & Schwartz, 1970), dia­
stolic blood pressure (Shapiro, Schwartz & Tursky, 1972), GSR (Fowler & 
Kimmel, 1962; Shapiro, Crider & Tursky, 1964) alpha waves (Kamiya, 1969; 
Peper, 1972) and skin temperature (Roberts, Kewman & MacDonald, 1973). 
These studies challenge the traditional view that autonomic processes 
can only be modified through classical conditioning. In demonstrating 
instrumental conditioning of visceral responses, Miller (1969) states 
that evidence for the historical view of the instrumental conditioning 
of voluntary skeletal responses and the classical conditioning of the 
autonomic visceral responses is lacking.
The use of biofeedback in learning the voluntary control of pre­
viously held involuntary autonomic processes has implications not only 
for learning theory but also for psychosomatic medicine (Birk, 1973; 
Miller, 1969; Shapiro & Schwartz, 1972). Miller (1969) states
3. . . the fact that glandular and visceral responses can be ins.tru- 
mentally learned opens up many new theoretical possibilities for the 
reinforcement of psychosomatic symptoms, (p. 464)
Shapiro and Schwartz (1972) also point out that biofeedback 
incorporates the instrumental learning concepts and techniques needed to 
understand the theoretical etiology of psychosomatic illness, and also 
provides methods for modifying psychosomatic symptoms. Biofeedback has 
been used as a therapeutic treatment for essential hypertension (Kristt 
& Engel, 1975; Moeller & Love, 1973), cardiac arrhythmias (Engel, 1973), 
Raynaud's disease (Surwit, 1973), migraine headaches (Sargent, Walters & 
Green, 1973), tension headaches (Budzynski, Stoyva & Adler, 1970; Wick- 
ramasekera, 1972), muscle retraining (Johnson & Garton, 1973), teaching 
facial expressions to the blind (Webb, 1974), modification of spasmodic 
torticollis (Cleeland, 1973), stuttering (Hanna, Wilfling & McNeill, 
1975), elimination of subvocal speech (Hardyck, Petrinovich & Ellsworth, 
1966), chronic anxiety (Raskin, Johnson & Rondestvedt, 1973; Townsend, 
House & Addario, 1975), ulcers (Welgan, 1974; Whitehead, Renault & Gol- 
diamond, 1975), epilepsy (Finley, Smith & Etherton, 1975; Sterman, Mac 
Donald & Stone, 1974), and asthma (Davis, Saunders, Greer & Chai, 1973).
Electromyogram (EMG) feedback training has been applied clini­
cally in a variety of therapeutic treatments including muscle retraining 
(Johnson & Garton, 1973), teaching facial expressions to the blind (Webb, 
1974), modification of spasmodic torticollis (Cleeland, 1973), stutter­
ing (Hanna, Wilfling & McNeil, 1975), elimination of subvocal speech 
(Hardyck et al., 1966), chronic anxiety (Raskin et al., 1973; Townsend 
et al., 1975), tension headaches (Budzynski et al., 1970; Wickramasekera, 
1972). EMG feedback has also been used as an adjunct treatment to
4facilitate systematic desensitization (Budzynski, 1973) and to facili­
tate relaxation in treating asthmatics (Davis et al., 1973).
Some researchers have argued that EMG feedback training should 
not be included in the area of biofeedback as it is a voluntary striate 
muscle response (Blanchard & Young, 1974). Roth (1975) points out that 
by restricting biofeedback to involuntary autonomic responses one is 
making the assumption that voluntary and involuntary responses can be 
classified according to which subdivision of the central nervous system 
they originate (i.e., somatic versus autonomic). This classification is 
inadequate in that voluntary control of an autonomically mediated 
response has been demonstrated (Lapides, Sweet & Lewis, 1957). Further­
more, the involuntary, habitual nature of the striate muscle response in 
tension headaches has also been reported (Shapiro & Schwartz, 1972; Roth, 
1975). Roth (1975) concludes
This evidence suggests that it may be more profitable to view bio­
feedback related responses in terms of the presence or absence of 
conditions for acquiring self control rather than simply anatomical 
origin per se. That is, biofeedback training would be said to con­
cern the conditioning of these bodily responses for which, in the 
normally functioning individual, the conditions necessary for the 
development of voluntary control over such response (e.g., immediate 
feedback about the behavior of the response and the availability of 
rewards contingent upon appropriate performance) are lacking. This 
conceptual approach, then would include EMG training among the bio­
feedback therapies. (p. 5)
This conceptual approach is also used by Green, Green & Walters 
(1974) in which they view biofeedback as encompassing the striate, 
autonomic and central nervous systems.
Role of Placebos in Biofeedback
Shapiro (1971) defines placebo as
5. . . any therapy, or that component of any therapy, that is delib­
erately used for its nonspecific, psychologic, or psychophysiologic 
effect, or that is used for its presumed specific effect on a 
patient, symptom or illness, but which, unknown to patient and 
therapist, is without specific activity for the condition being 
treated. (p. 440)
He adds
A placebo, when used as a control in experimental studies, is 
defined as a substance or procedure that is without specific activ­
ity for the condition being evaluated. (p. 440)
Traditional psychotherapy research has recognized the important 
role of placebo factors in psychotherapy outcome (Frank, 1961; Gold­
stein, 1962; Shapiro, 1971). Most well-designed studies investigating 
the-efficacy of various therapeutic methods incorporate a placebo- 
control in order to separate the specific and nonspecific factors which 
are involved in the treatment technique (Bergin, 1971). Although the 
label of "placebo" has a negative connotation when applied to a treat­
ment procedure (Shapiro, 1971), Bergin (1971) points out that placebo 
factors should not be considered artifacts, but rather as variables 
which must be studied, understood and incorporated to effect the most 
therapeutic change. The interaction of placebos and psychotherapy must 
be studied so that the mechanism through which the placebos work can be 
isolated and consequently utilized as a specific therapeutic tool. The 
important issues surrounding psychotherapy in general (i.e., placebos) 
must also be directed to biofeedback as a therapy, as this will result 
in a more effective framework with which to evaluate the efficacy of 
biofeedback (Blanchard & Young, 1974). Concern over the control of 
placebo variables has been stated by a number of investigators involved 
in biofeedback research (Beatty, 1972; Birk, 1973; Blanchard & Young, 
1974; Budzynski, 1973; Miller, 1974; Shapiro & Schwartz, 1972; Strobel &
6Glueck, 1973). Miller (1974) stresses that any therapeutic gain demon­
strated in biofeedback studies may not be due to specific factors of the 
treatment itself, but rather to the nonspecific placebo factors (i.e., 
hope, attention, suggestion and expectancy). He goes on
From the scientific point of view, it is important to know whether 
the effects of a technique are due to its specific rationale or to a 
nonspecific placebo effect. Additional research on the mechanism of 
a treatment often leads to significant improvements and to new appli­
cations, but it is a waste of time to investigate the mechanisms of 
a treatment as though the effects were specific to its rationale, 
when in fact they are due to nonspecific placebo effects. (p. xiii)
Interpersonal Placebos
In investigating the role of placebos in psychotherapy, the 
interpersonal relationship between the therapist and client has been 
proposed as one of the important common (i.e., nonspecific) elements in 
determining a successful outcome in psychotherapy (Goldstein, 1962; 
Rosenthal & Frank, 1956; Shapiro, 1959, 1971). Goldstein (1962) states 
that it appears that the major component of activating placebo effects 
in psychotherapy is through the client-therapist relationship.
The mechanism through which placebo factors are activated 
include the induction of the client's expectancy of gain, as Frank 
(1961) states that it is through the elicitation of faith and hope that 
placebos can effect therapeutic gain. A distinction between placebos 
and the mechanism through which they operate must be made. Placebos are 
any nonspecific factors which operate in treatment methods, but placebos 
can be said to operate through different mechanisms, one of which is the 
elicitation of a subject's expectancy of gain through instructional
manipulation.
7Expectancy of gain is a concept employed by Goldstein (1962) to 
describe those expectations a subject acquires through his participation 
in therapy. The clinical application of biofeedback has been acclaimed 
a panacea of psychosomatic illness by popular press (Blanchard & Young, 
1974). This enhancement of client's expectations has been suggested as 
an important factor in the outcome of biofeedback studies (Budzynski, 
1973; Miller, 1974). Studies have demonstrated that expectancy (i.e., 
manipulation of cognitive set through instructional information) does 
alter physiological functioning (Barber, 1964; Graham, Kabler & Graham, 
1962; Sternbach, 1964). Sternbach (1964) presented subjects with three 
drugs which were said to have three different effects on gastric motil­
ity— relaxation, stimulation and placebo (no effect). In actuality all 
the drugs were small plastic coated magnets used to detect gastric 
motility. Results indicated that the effects on gastric motility were 
significantly related to the direction specified by the instructions. 
Another study with similar results involved the precipitation of asthma 
attacks through injection of saline solution presented instructionally 
as an allergin (Luparello, Lyons, Bleeker & McFadden, 1969). Again 
results demonstrated the effect of instructions on physiological proces­
ses as 50% of the j3s experienced asthma attacks.
These studies on the role of expectancy inducted by instruc­
tional manipulations have implications for the role of cognitive media­
tors in the operant conditioning of autonomic processes. Although it 
has been stated that the degree of specificity of response cannot be 
accounted for by cognitive factors (Crider, Schwartz & Shnidman, 1969), 
the importance of cognitive mediation has also been argued (Katkin &
8Murray, 1968). If, as stated above, instructional expectancy manipula­
tions do alter physiological activities, then the process of altering 
expectancies may be an important phenomena to study in biofeedback 
research for both its clinical and theoretical implications.
Although most biofeedback studies have assumed that instructions 
to both treatment and control groups were identical (Shapiro & Schwartz, 
1972) perhaps the subtle interpersonal placebo factors may have created 
a differential expectancy set between groups. A positive expectation on 
the part of the patient may be a prerequisite for therapeutic gains 
(Schwartz, 1973). Positive expectations can be transmitted from thera­
pist to the patient by statements of the therapist's confidence in the 
patient's capacity to benefit from the procedures, by statements of the 
therapists' confidence in the efficacy of the treatment, and from cues 
in the treatment situation or setting (Frank, 1959). These three fac­
tors help foster and promote a subject's expectancy of relief.
It appears that the interpersonal interactions in therapy may be 
instrumental in the activation of placebogenic factors through the 
enhancement of subject expectancy. The general approach of enhancing 
subject expectancy is accomplished through pre-task instructional manipu­
lation. Research in the area of biofeedback with respect to pre-task 
instructional manipulation is limited. Leeb, Fahrion and French (1974) 
demonstrated that pre-task instructional manipulations (i.e. , positive, 
negative, neutral) resulted in significant differences between groups in 
their ability to do a hand temperature task. Those Ss who received posi­
tive instructions (i.e., instructions conveying experimenter's confi­
dence) were able to raise hand temperature significantly when compared
9to those S_s who received negative instructions. Valle and Levine (1975) 
investigated the effects of expectancy on alpha wave control, again 
incorporating the expectancy manipulation through pre-task instructions. 
The 2 x 2  study involved a task variable (i.e., enhance alpha versus 
suppress alpha) and an expectancy variable (i.e., instructions that S[s 
were enhancing alpha versus instructions that j3s were suppressing alpha) 
Those Ss who were led to believe they were enhancing alpha, independent 
of actual task, controlled alpha significantly better than those Ss lead 
to believe they were suppressing alpha.
These studies, following the traditional design used in expec­
tancy studies have demonstrated the relevance of the mechanism of 
placebo factors (i.e., expectancy) in biofeedback training. Yet Wilkins 
(1973), in a review of research in the area of induced expectancy states 
points out that subject expectancy manipulations have yet to be convinc­
ingly demonstrated due to theoretical and methodological problems.
First, expectancy states which originally were used to describe a phe­
nomena in drug research, have now been used in explaining causal rela­
tionships with little empirical evidence. Secondly, expectancy trait 
(i.e., general attitude toward healing sources) have been totally con­
founded with expectancy state (those expectations induced through direct 
experimental manipulation). A third problem is concerned with the cir­
cularity of the definition of expectancy in studies. He states that 
traditionally there has been no independent measure of the expectancy 
manipulation other than the dependent outcome measure. If the expec­
tancy manipulation resulted in differential outcome as measured by the 
dependent variable, it was assumed that the expectancy factor caused
10
this difference. If there was no differential outcome in the dependent 
variable the expectancy manipulation was said to be ineffective rather 
than it had no effect on the dependent variable. In other words, the 
traditional definition of expectancy was circular. Wilkins goes on to 
point out that those studies which have provided for an independent 
measurement of expectancy (Grosz, 1968; Imber, Pande, Frank, Hoehnsaric, 
Stone & Wargo, 1970) have obtained nonsignificant results.
Roth (1975) incorporated some of these suggestions in his inves­
tigation of expectancy effects on an EMG task. The expectancy manipula­
tion involved the presentation of positive versus neutral pre-task ver­
bal instructions. An independent verification of the expectancy manipu­
lation was incorporated into the design of the study with the use of a 
self-report questionnaire. This questionnaire also allowed the compari­
son of expectancy "trait" versus expectancy "state" as specific ques­
tions concerning this distinction were incorporated into the question­
naire (Lott, 1972). The independent measure of the expectancy manipula­
tion verified that those J>s who received positive pre-verbal instruc­
tions reported a higher expectancy of gain than those Ss receiving the 
neutral instructions. However, in terms of the dependent EMG measure, 
there were significant but paradoxical results in that those 5^s receiv­
ing neutral instructions significantly lowered EMG frontalis levels when 
compared with positive instruction groups. These results were explained 
in terms of over-motivation and evaluation apprehension.
The information included in pre-verbal instructions would appear 
to be a critical variable in light of Roth's (1975) results. Presenta­
tion of positive biofeedback research (Wickramasekera, 1974), statements
11
concerning the confidence of the therapist in the client's ability to 
perforin the task (Leeb et al., 1974), statements by the therapist as to 
benefits the subject will gain (Roth, 1975), and statements by the ther­
apists concerning his confidence in and experience with the treatment 
procedure (Roth, 1975) have all been used to induce positive subject 
expectancies. The studies cited above have included two components in 
their pre-task instructions: 1) information about biofeedback procedure 
and the confidence in that procedure, and 2) the therapists' confidence 
in the subject's abilities to do the task and benefit from the procedure. 
The first component seems to involve the subject's awareness of the pro­
cedure and responses he is learning to control. Recent investigations 
(Bergman & Johnson, 1972) have demonstrated the efficacy of informing Ss 
as to desired response. By including both components the potency of an 
expectancy manipulation would appear to be enhanced.
Situational Placebos
In his review article on placebo factors, Shapiro (1971) 
included treatment procedures and apparatus under the heading of situa­
tional placebos. Although most research presented in this area concern 
drugs and drug administrations (Fisher & Olin, 1956; Garetz, 1962;
Leslie, 1954; Wolf, 1959), Shapiro states
Even greater psychologic response, and placebo effects, would be 
expected with injections, various complicated procedures, and 
impressive machines (p. 450).
The belief in the efficacy of the western world's scientific 
approach to healing is an important factor which supports the potency of 
the placebo effect of machines (Frank, 1961; Lynch, 1973). Schwitzgebel
12
and Traugott (1968) note that many definitions of placebo refer only to 
medicines or procedures and they contend that the definition could be 
expanded to include "any object" which is used for its nonspecific 
placebo effect.
This expanded definition could include any mechanical apparatus, 
therapeutic devices or electronic equipment within the realm of placebo 
if these objects were used for their nonspecific effects. In a study of 
the placebo effects of machinery a three trial design was used with a 
motor steadiness task as the dependent measure (Schwitzgebel & Traugott, 
1968). The subjects were divided into an impair group (i.e., instruc­
tions indicated current would have a disruptive influence) and an 
improved group (i.e., instructions indicated current would have a facili- 
tative effect). The following procedure was then followed:
The experimenter then swabbed the subject's dominant arm with the 
electrode solution, applied the electrode paste, and carefully 
attached the electrodes so that they were firm but comfortable.
When the experimenter was sure that the subject was watching the 
ammeter scale, he turned on the signal generator and slowly adjusted 
it until the ammeter scale read exactly fifty microamperes; in fact, 
no current was administered.
Results indicated that 25% of the Ss felt the current. The 
improved group significantly improved their performance on the motor 
steadiness tasks while the impaired group did not show any significant 
impairment or improvement in performance.
The placebogenic effects of therapeutic devices has also been 
suggested in studies investigating the efficacy of cerebral electro- 
therapeutic treatment of depressives (Marshall & Izard, 1974; Passini, 
Watson & Herder, 1975). Cerebral electrotherapy involves the applica­
tion of a small current to the brain through electrodes placed behind
13
the ears and over the eyelids. No significant differences in improve­
ment between the electrotherapy and placebo therapy (i.e., a therapy not 
distinguishable from electrotherapy) groups were found and it was con­
cluded that improvement in the groups could be due in large part to 
placebo effects. Manipulations of situational setting through the pres­
ence and absence of impressive apparatus (i.e., electronic console with 
flashing lights and polygraph recorder) has also been used in order to 
enhance subject expectancy (Imber, Pande, Frank, Hoehnsaric, Stone & 
Wargo, 1970). An independent verification of the instrument manipula­
tion demonstrated that a differential expectancy state was not induced 
by the manipulation.
Wickramasekera (1972, 1974) and Miller (1974) have speculated 
about the role of impressive apparatus and its effect upon Ss during the 
biofeedback training. A review of the literature reveals no studies 
which have investigated the effect of situational placebos on EMG per­
formance. In light of the above studies, it appears that more research 
is needed to delineate the placebogenic effect of apparatus on EMG feed­
back performance.
Statement of the Problem
Although biofeedback appears to have many promising clinical 
applications, much of the research supporting the efficacy of biofeed­
back has been based on anecdotal cases (Blanchard & Young, 1974) or 
poorly designed research studies which have lacked adequate controls 
(Budzynski, 1973). Future research must be designed to sort out the
14
specific variables or components which are active in the biofeedback 
procedures (Blanchard & Young, 1974; Budzynski, 1973; Miller, 1974).
The present study investigated the significance of placebo fac­
tors in the performance of an EMG training task. One of the placebo 
variables involved the induction of a positive expectancy state through 
the manipulation of pre-training instructions. The differential manipu­
lation of instruction varied the information concerning positive 
research findings, the ease with which the task could be accomplished 
and the benefit to be gained. The second placebo variable studied 
involved a situational placebo factor— that of the impact of impressive 
instrumentation. The operational definition of the apparatus variable 
incorporated the presence or absence of impressive apparatus (i.e., 
oscilliscope and control panels) beyond the use of the myograph and 
integrator unit.
Following previous research (Frank, 1959; Leeb et al., 1974;
Roth, 1975; Wickramasekera, 1972) the expectancy manipulation included 
an informational component which was intended to convey the researcher's 
confidence in the procedure and empirical support for the procedure, and 
a second component which was intended to convey the therapist's confi­
dence in the Ss ability to carry out the task as well as benefit from it. 
Stroebel and Glueck (1973) have noted that a balance is needed between 
expectations and actual performance in order to obtain a favorable prog­
nostic outcome. If a subject's expectancies are well above his actual 
ability to perform the task his future prognosis in terms of outcome 
will be poor. Studies have indicated that overmotivation leading to a 
decrement in performance can be a result of positive expectancy
15
manipulations (Aletky & Carlin, 1975; Roth, 1975). In order to minimize 
subject overmotivation and apprehension, an attempt was made to present 
the pre-task instructions in a warm and friendly manner. The importance 
of these interpersonal characteristics have been noted in both biofeed­
back research (Fico, 1975; Lynch, 1973; Shapiro & Schwartz, 1972) and 
general psychotherapy (Bergin & Garfield, 1971). Following Wilkin's 
(1973) suggestion for an independent expectancy measure a questionnaire 
was used to verify the induction of a differential expectancy state.
The main dependent measure was the EMG level of the frontalis 
muscle. The use of the frontalis muscle has been documented in the 
treatment of tension headaches (Budzynski, Stoyva, Adler & Mullaney, 
1973; Wickramasekera, 1972). It was found that frontalis muscle levels 
significantly differentiate between anxious subjects and controls (Malmo 
& Smith, 1955). It has also been reported that the training of the 
frontalis muscle tends to generalize to other muscles in the cephalic 
and neck regions (Budzynski et al., 1973).
CHAPTER II
METHOD
General Design
The present study examined the role of placebo factors in an EMG 
training task using a 2 x 2 x 2 factorial design with repeated measures 
on one factor (Winer, 1971). The two placebo factors examined were an 
expectancy placebo and an apparatus placebo. The expectancy manipula­
tion involved the presence or absence of positive information concerning 
the efficacy of the procedure and the benefit the subject would incur. 
The apparatus manipulation involved the presence or absence of auxiliary 
(i.e., nonessential) apparatus. The factorial design thus resulted in 
four between subject groups: expectancy placebo-apparatus placebo (EA), 
expectancy placebo-no apparatus placebo (ENA), no expectancy placebo- 
apparatus placebo (NEA), and no expectancy manipulation-no apparatus 
placebo (NENA). Forty-eight male subjects were randomly assigned to one 
of these four experimental groups.
Both the expectancy placebo manipulation and the apparatus pla­
cebo manipulation were made following a six minute baseline session.
Task instructions concerning the EMG training procedure were presented 
following a second four minute baseline, and each subject then completed 
two twelve minute training sessions during which they received auditory 
analogue feedback. The dependent measure was the integrated EMG tension 
levels of the frontalis muscle as recorded by a myograph and integrator
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unit. Each subject also received a post-session questionnaire which was 
used to verify independently the expectancy manipulation, examine the 
expectancy trait and state conditions for each subject and investigate 
the subject's attitudes toward the task and the experimenter.
Subjects
Volunteer male subjects were obtained from the introductory 
psychology sections at the University of North Dakota. Subjects were 
informed that they would receive credit for participation in the research. 
Subjects who indicated an interest in participating in an experiment in 
relaxation were then asked to fill out a screening questionnaire. Those 
subjects who indicated any previous history of epilepsy, diabetes, car­
diac difficulty, tension headaches, relaxation training or biofeedback 
training were excluded from the available subject population. Forty- 
eight male subjects were then selected from this population. Each sub­
ject was contacted and an appointment was made with instructions given 
as to the location of Psychological Service Center where the experiment 
was to be held.
Apparatus and Setting
A small carpeted room with desk, reclining chair and drapes was 
the setting for the experiment. The apparatus and necessary supplies 
were on the desk and shelf in full view of the subject. Illumination 
was reduced while EMG levels were recorded.
A Biofeedback Technology, Inc. (BFT) 401 myograph unit was used 
to measure the electrical potential of the frontalis muscle. The BFT
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401 amplifies the electrical signal from the muscles and filters the 
signal eliminating artifactual noise from other physiological activities. 
The BFT 401 is also shielded from electrical interference from environ­
mental sources (below 1 microvolt RMS). The BFT 215 integrator enables 
the precise quantification of muscle potential in the form of a digital 
readout. The unit integrates the muscle potential over a one minute 
period and provides a digital readout of the average peak to peak micro­
volt level over that time period.
Two nondisposable BFT silver silver-chloride electrodes were 
placed 1 inch above each eyebrow 4 inches apart (Davis, 1959). A third 
reference electrode was placed midline on the forehead between the two 
active electrodes. An elastic adjustable headband was used to hold the 
electrodes firmly, yet comfortably, in place. Before the electrodes 
were attached, the subjects' foreheads were briskly rubbed with skin 
abrasive and electrode paste was applied in order to obtain less than 
10,000 ohm resistance.
The BFT 401 myogram unit drives a standard 8 ohm speaker which 
provided a constant auditory tone to the subject. The pitch of the 
auditory tone varied proportionately in relation to the subject's muscle 
tension. As muscle tension decreased, the pitch decreased proportion­
ately; as the muscle tension increased, the pitch increased proportion­
ately. This allowed the subject to have continuous feedback of his
muscle tension.
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Procedure
Upon arriving at the Psychological Service Center, the experi­
menter introduced himself to the subject and directed him to the appro­
priate room. The subject was asked to sit in the recliner located next 
to the experimenter's desk. The .E informed the Ss that the study 
involved the use of biofeedback in relaxation training. The E_ then pro­
ceeded with the attachment of electrodes and baseline data collection.
Determination of Baseline Periods. Although previous studies 
(Alexander, 1975; Haynes, Moseley & McGowan, 1975; Kinsman, O'Banion, 
Robinson & Stadenmayer, 1975; Roth, 1975) used five minute baseline 
periods, a pilot study was undertaken to determine if five minutes was 
adequate for baseline stabilization. Four subjects were asked to relax 
for approximately twenty-eight minutes while EMG levels were recorded 
with no feedback. A three minute sliding average was calculated for 
each subject. Results of the pilot study can be found in Appendix A. 
Results indicated that a ten minute period was a more adequate period 
for stabilization of baseline (nonfeedback) EMG levels.
Following the results of the pilot study, a modified ten minute 
baseline period was incorporated. Before the manipulation of the vari­
ables under investigation, there was a six minute baseline period in 
which muscle tension was recorded but feedback was, withheld from the 
subject. Following the manipulation of the expectancy and apparatus 
variables, a second four minute baseline period was used to observe any 
baseline changes due to the variable intervention. A total of ten
minutes of baseline level was recorded for each subject.
20
Collection of Baseline 1 Data. The electrodes were attached to 
the subject's frontalis muscle, and subjects were reassured that there 
was no possibility of shock. Subjects were then instructed to lay back 
in the recliner, close their eyes, and relax for a six minute period.
Expectancy Placebo Manipulation. Following the six minute base­
line, the experimenter presented the pre-task expectancy manipulation to 
the Ss in the EA and ENA conditions. The expectancy manipulation con­
sisted of two components: 1) information concerning past research in 
biofeedback and expressing the therapist's confidence in the procedure, 
and 2) information expressing the therapist's confidence in the subject's 
ability to do the task and benefit from the procedure. The expectancy 
manipulation was presented conversationally to the subject, lasting 
about two minutes. The content of the expectancy manipulation can be 
found in Appendix B.
Those Ss not receiving the expectancy manipulation (NEA and 
NENA) were engaged in a similar two minute conversation, but the content 
of the discussion was aimed at the subject's interests and vocational 
pursuits. An attempt was made to equalize the impact of interpersonal 
variables such as warmth and friendliness in both the expectancy and no 
expectancy groups.
Apparatus Placebo Manipulation. Those jSs in the apparatus pres­
ent condition were told that before the final segment of the study could 
continue more equipment would be necessary for recording purposes. The 
_E then brought in the placebo apparatus (i.e., non-essential
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oscilliscope, control panels, and miscellaneous wires). This apparatus 
was placed in full view of the subject.
Those Ss in the no apparatus placebo conditions were instructed 
that before the final segment of the study could proceed a speaker was 
needed. The El then left the room and returned with the speaker.
Collection of Baseline 2 Data. All Ss were then asked to again 
relax for another four minutes in order to check to see if all the equip­
ment was functioning properly.
Task Instructions. Following the baseline periods and variable 
interventions each was informed of the EMG training task to be com­
pleted. Instructions included information concerning the relationship 
between the pitch of the tone and the muscle tension in the head region. 
Emphasis was placed on relaxing and making the tone decrease in pitch. 
Caution was given not to try too hard as this interfered with relaxation 
and Ss were also instructed not to fall asleep. The S_s were then 
informed that there would be two twelve minute sessions with a two min­
ute break between sessions. Again, the subjects were reminded to remain 
motionless, with eyes closed and to focus their attention on making the 
tone go down in pitch. The content of the task instructions can be 
found in Appendix C.
Post-Session Questionnaire. A post-session questionnaire was 
given to each upon completion of the EMG training session (see Appen­
dix D). This questionnaire was assembled and utilized by Roth (1975) in 
his investigation of expectancy manipulations on EMG training. The
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questionnaire was a self-report measure composed of thirteen items, 
including eight Likert-scale items and a semantic differential. The 
questionnaire was structured to a) verify the expectancy manipulation 
(questions 4, 7 and 8), b) examine the concept of expectancy trait ver­
sus expectancy state (questions 4, 5, 6, 7 and 8), c) investigate the 
subject's perception of interpersonal variables (questions 9a through 
9f), d) assess subject's perception of the level of relaxation (question 
1), and e) solicit the subject's perception of the task (i.e., difficul­
ty, effort extended, strategy used) (questions 2, 3 and 12). In addi­
tion, information concerning any previous knowledge of the study and 
whether the J3s fell asleep during the study were requested (questions 11 
and 13).
Following the completion of the questionnaire each _S was asked 
not to discuss the experiment until the study had terminated. J3s were 
also informed that they would receive a summary of the experiment and 
results upon completion of the study.
CHAPTER III
RESULTS
The two dependent measures utilized in this study were an EMG 
frontalis measure and a self-report questionnaire. The self-report 
questionnaire was utilized as an independent verification of the effi­
cacy of the expectancy instructions. The EMG measure was used to 
investigate the effects of the placebogenic variables on EMG performance.
Questionnaire Dependent Variable
A 2 x 2 (Expectancy X Apparatus) AN9VA was performed on the 
eight Likert-scale items and on the six semantic differential items of 
the post session questionnaire, to determine if the subjects responded 
differentially in terms of experimental condition. The simple cell 
means and standard deviations as well as the 2 x 2  ANOVA results for the 
Likert-scale items can be found in Table 1 while those for the semantic 
differential items can be found in Table 2.
The independent check on the effectiveness of the expectancy 
instructions involved Likert-scale Items 4 and 8. Results indicate that 
Item 8, which dealt with subject's perception of benefit to be gained, 
had a significant expectancy main effect F_ (1, 44) = 4.10, jd .046.
Those subjects who received the positive expectancy manipulation 
reported greater anticipation of benefit than those subjects not
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TABLE 1
SIMPLE EFFECT CELL MEANS, STANDARD DEVIATIONS AND F-RATIOS FOR LIKERT SCALE ITEMS
Group Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8
EA Mean 4.583 5.167 3.917 4.083 4.750 2.833 3.583 4.083
SD .669 .577 .996 1.084 .866 1.467 .996 .669
ENA Mean 5.000 4.083 3. 750 2.500 4.750 2.917 2.583 3.833
SD .739 1.240 1.357 1.143 1.138 1.881 1.084 1.115
NEA Mean 4.667 4.500 4.000 3.333 5.167 2.250 3.167 3.250
SD .778 1.087 1. 206 .985 .937 1.485 1.030 .965
NENA Mean 4.167 4.833 4.333 4.167 4.283 2.833 3.000 3.583
SD .778 .937 .985 .835 .515 1.467 1.348 .900
F-ratio for apparatus .039 1.687 .063 .171 1.280 .531 3.237 .024
F-Ratio for expectancy 3.194 .021 1.014 .019 .235 .531 .000 4.104*
F-Ratio for interaction 4.771* 6.125* .571 5.491* 1. 280 2.990 1.652 1.190
*£<. 05
TABLE 2
IT)CN
SIMPLE EFFECT CELL MEANS, STANDARD DEVIATIONS AND F-RATIOS FOR SEMANTIC DIFFERENTIAL ITEMS
Group Item 9a Item 9b Item 9c Item 9d Item 9e Item 9f
EA Mean 6.583 6.583 6.500 6.667 6.500 6.167
SD .669 .669 .905 .651 .798 .519
ENA Mean 6.000 6.250 6.167 6.500 6.167 6.250
SD .739 .452 .937 .522 .835 .965
NEA Mean 6.333 6. 250 6.250 6.583 5.917 6.333
SD .492 .754 .754 .669 .669 .651
NENA Mean 6.250 6.750 6.583 6.833 6. 500 6. 583
SD .622 .452 .515 .389 .674 .669
F-Ratio for apparatus 3.290 .234 .000 .064 .336 . 224
F-Ratio for expectancy .000 .234 .132 .579 .336 .504
F-Ratio for interaction 1.850 5.851* 2.108 1.608 4.512* .056
*£<. 05
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receiving the expectancy instructions. Item 4, which deals with expec­
tancy of successful relaxation following the instructions, had a signifi­
cant expectancy x apparatus interaction, _F (1, 44) = 5.491, £=.022.
The EA and NENA treatment condition subjects responded significantly 
higher in terms of expected successful relaxation. No significant main 
effects or interactions on Items 5, 6 or 7 indicated that subjects did 
not differ significantly in terms of general expectations of psycho­
therapy and scientific techniques. These results lend support to the 
effectiveness of the expectancy manipulations.
Two other significant interactions were found. These were on 
Items 1 and 2, F (1, 44) = 4.771, £=.03 and F (1, 44) = 6.125, £=.016 
respectively. Upon inspection of the simple cell means for the treat­
ment groups (Table 1) the two experimental groups (EA and NENA) who 
reported feeling significantly less relaxed also reported that they 
tried harder, even though S_s had been cautioned about trying too hard in 
the task instruction. This inverse relationship between effort extended 
and subjective feelings of relaxation was also found by Roth (1975).
The subjects did not differ significantly in their perception of the 
task difficulty (Item 3).
Of the semantic differential items (Table 2) the 2 x 2  ANOVA on
\
Item 9b, which was the incompetent-competent scale, resulted in a sig­
nificant expectancy x apparatus interaction, ]? (1, 44) = 5.851, £=.019. 
Item 9e, which deals with a nonprofessional-professional dimension, also 
had a significant expectancy x apparatus interaction, _F (1, 44) = 4.512, 
£=.037. Inspection of simple cell means (Table 2) revealed that the EA 
and NENA groups perceived the _E as more professional and competent. The
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same groups that perceived the experimenter as more competent and pro­
fessional (EA and NENA) were the treatment groups that anticipated sig­
nificantly higher successful outcomes.
In viewing the significant interactions obtained, there is a 
consistency in terms of the treatment conditions involved. The treat­
ment groups which responded significantly higher in terms of expected 
successful relaxation (i.e., EA and NENA) also perceived the experi­
menter as more professional and competent. These same treatment groups 
also reported that they tried harder and felt less relaxed. These 
results indicate that those groups which subjectively expected greater 
relaxation may have consequently tried too hard during the task and thus 
reported less relaxation. Although these interactions appear to be con­
sistent as to the treatment conditions involved (i.e., EA and NENA), 
these specific relationships (i.e., interactions) cannot be accounted 
for in terms of the research design.
No significant main effects or interactions were observed on the 
other semantic differential dimensions. All experimental groups per­
ceived the _E as warm, confident, friendly, and concerned about the 
subject.
Inspection of the Items 10, 11, and 13 on the questionnaire 
revealed that 29 out of 48 subjects had prior knowledge of biofeedback,
1 subject had fallen asleep for a short period and 9 subjects had spoken 
to other subjects and had been informed that the study involved relaxing 
in a chair for certain time periods.
In summarizing the results of the questionnaire items, there was 
support for the effectiveness of the expectancy manipulation as the
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expectancy groups anticipated more benefit than the no expectancy groups. 
Another result was that the experimental groups which reported trying 
harder on the task, also reported that they felt less relaxed (EA and 
NENA). Finally, the experimental groups which perceived the experi­
menter as more competent and professional reported that they antici­
pated more successful outcomes (EA and NENA).
EMG Dependent Measure
Integrated EMG frontalis scores were recorded for each subject 
over two baseline periods with no feedback (6 minute and 4 minute periods 
respectively). The two EMG training sessions consisted of 12 minute 
periods. For each subject means for Baseline 1, Baseline 2, Session 1 
and Session 2 were computed. Table 3 provides the average EMG levels 
for these periods by each treatment condition. A trial by trial average 
for each treatment condition is seen in Figure 1.
TABLE 3
MEANS AND STANDARD DEVIATIONS FOR EMG SCORES (MICROVOLTS) 
FOR BASELINES, SESSION 1, SESSION 2 BY TREATMENT GROUP
Group Baseline 1 Baseline 2 Baseline T Session 1 Session 2
EA Mean 7.651 7.417 7.557 7.215 6.506
SD 2.917 2.840 2.676 3.618 3.325
ENA Mean 8.114 6.494 7.466 5.588 4.989
SD 2.190 2.851 2. 324 2. 200 2.569
NEA Mean 7.090 7.435 7.228 6.749 6.287
SD 2.354 3.471 2.455 4.305 4.382
NENA Mean 7.012 6.119 6.655 5.271 4.856
SD 2.909 2.397 2.557 2.416 2.912
1-Due to mechanical failure of the equipment, data from three sub­
jects were excluded from the research. Three additional Ss were random­
ly assigned to replace them. The EMG scores for the excluded subjects 
can be found in Appendix E.
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The Baseline 2 period was incorporated to assess the effects of 
the introduction of the independent variables on the baseline EMG levels. 
The effect of the variable intervention was analyzed in two ways. First 
a Sandler's A was performed to check for differences between Baseline 1 
and Baseline 2 (Table 4). When all treatment conditions were combined, 
no significant difference between Baseline 1 and Baseline 2 was obtained. 
When analyzed by treatment condition, only in the ENA group was Baseline 
1 significantly■different from Baseline 2, A (11) = .172, £<.01. For 
the ENA condition Baseline 1 was significantly higher than Baseline 2. 
Inspection of Table 3 and Figure 1 suggests that this difference can be 
attributed to a habituation or stabilization of the baseline level. As 
indicated by the pilot study a ten minute period is warranted for base­
line stabilization.
TABLE 4
SUMMARY FOR SANDLER'S A BETWEEN BASELINE 1 AND BASELINE 2
Group Baseline 1 Baseline 2 df Sandler's A
Total 7.467 6.866 47 .317
EA 7.651 7.417 11 20.734
ENA 8.114 6.494 11 .172*
NEA 7.090 7.435 11 5.29
NENA 7.012 6.119 11 .937
*^ < .01.
Fig. 1. Mean EMG scores across treatment conditions EA, 
ENA, NEA, NENA for Baseline 1, Baseline 2, Session 1 and Session 2 
for unadjusted data.
BASELINE 
SESSION
HI
H
■P* m o  si oo O O• • • • ~ • *_ •o o o o o o o
•I------ 1-------1------ 1-------1-------1------ 1------ 1------ 1-------1-------1-------1-------\
MEAN EMG (microvolts) —
KJ
GJ
A
Ln
O
KJ
u>
KJ
CJ
A
Ln
O
CD
O
o
KJ
32
The second analysis involved a 2 x 2 ANOVA (Apparatus X Expec­
tancy) on the Baseline 2 EMG levels (Table 5). Although there was vari­
ation in the Baseline 2 levels among treatment groups, no significant 
main effects nor interaction were obtained.
TABLE 5
SUMMARY ANOVA FOR MEAN EMG BASELINE 2 SCORES
Source df MS F
Expectancy (EXP) 1 .382 .054
Apparatus (APP) 1 15.039 2.129
EXP X APP 1 .464 . 066
Subj ects 44 7.065
The introduction of the expectancy and apparatus variables 
appeared to have no significant effect on the baseline, therefore in 
later analysis of the data a pooled estimate of the baseline was used.
The baseline total was the weighted average of Baseline 1 and Baseline 2.
The importance of initial EMG baseline levels as determinants of 
later EMG reduction led to a check of the random selection of subjects 
to experimental groups. A 2 x 2 (expectancy x apparatus) analysis of 
variance was computed with the baseline total used as the dependent 
variable. Table 6 indicates that the treatment conditions did not dif­
fer significantly in terms of initial baseline levels.
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TABLE 6
SUMMARY ANOVA FOR MEAN EMG BASELINE TOTAL SCORES
Source df MS F
Expectancy (EXP) 1 1.327 .211
Apparatus (APP) 1 3.90 .621
EXP X APP 1 .696 .111
Sub j ects 44 6.282
The main analysis of the data involved an Expectancy X Apparatus 
X Session analysis of variance on the mean unadjusted EMG scores (Table 
7). A significant sessions effect was obtained, _F (1, 44) = 6.087, 
j>=.018. Inspection of the simple cell means (Table 3) revealed that 
EMG levels for Session 2 were significantly lower than those for Session 
1. There were no significant main effects for Apparatus or Expectancy, 
nor were there any significant interactions.
TABLE 7
SUMMARY ANOVA FOR UNADJUSTED MEAN EMG SCORES
Source df MS F
Between Subjects
Apparatus (APP) 1 73.3249 3.9050
Expectancy (EXP) 1 .0651 .0035
EXP X APP 1 1.8426 .0981
Subjects (SUB) 44 18.7771
Within Subjects
Session (SES) 1 14.9626 6.0873*
EXP X SES 1 .8251 .3357
APP X SES 1 2.7001 1.0985
EXP X APP X SES 1 1.1051 .4496
SES X SUB 44 2.4580
Total 95 2.9353
*p<.05
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A covariate adjustment was made on the EMG scores using the 
average baseline score. The variance of EMG scores which could be pre­
dicted from initial baseline levels was removed and adjusted EMG scores 
were computed. Figure 2 presents a trial by trial graph of the mean 
adjusted EMG scores for each group. Table 8 presents the mean adjusted 
EMG scores for Session 1 and Session 2 by treatment group.
TABLE 8
MEANS AND STANDARD DEVIATIONS FOR EMG SCORES FOR 
SESSION 1 AND 2 ADJUSTED FOR BASELINE EMG
Group Session 1 Session 2
EA Mean 5.658 5.633
SD 1.723 2.948
ENA Mean 4.133 4.092
SD .928 1.585
NEA Mean 5.542 5.617
SD 3.115 3.527
NENA Mean 4.642 4.675
SD 1.708 1.734
A second 2 x 2 x 2  analysis of variance (Expectancy X Apparatus 
X Sessions) was then performed on the adjusted data (Table 9). The 
apparatus main effect was significant, _F (1, 43) = 4.073, £=.0498. 
Inspection of the simple cells for treatment groups in Table 9 revealed 
that those subjects who did not receive the apparatus presentation 
reduced their EMG levels significantly over those subjects who received 
the apparatus presentation. There were no significant main effects for 
expectancy or sessions, nor were there any significant interactions.
Since no significant session effect was obtained an additional 
trend analysis was performed to test for a significant linear trend over
Fig. 2. Mean EMG scores across treatment conditions for EA, 
ENA, NEA, NENA for Session 1 and Session 2 for adjusted data.
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the twenty-four one minute trials. The dependent measure was the mean 
adjusted EMG score for each trial. Inspection of Table 10 revealed no 
significant linear trend for the total group nor for the individual 
treatment groups.
TABLE 9
SUMMARY ANOVA FOR MEAN EMG SCORES WITH COVARIATE 
ADJUSTMENT FOR BASELINE
Source df MS F
Between Subjects
Apparatus (APP) 1 36.138 4.073*
Expectancy (EXP) 1 1.378 .1553
EXP X APP 1 2.251 . 2537
Subject (SUB) 43 8.872
Within Subjects
Session (SES) 1 .0026 .0014
EXP X SES 1 .0051 .0027
APP X SES 1 .04594 .0242
EXP X APP X SES 1 .00094 .0005
SES X SUB 43 1.902
Total 93
*£<.05
In summary, a check on the random assignment of subjects to 
treatment groups indicated no significant differences between treatment 
groups in terms of baseline levels. Analysis of the EMG baselines 
demonstrated that the introduction of the placebo variables did not 
result in significant changes in baseline levels. Therefore, the Base­
line 1 and Baseline 2 periods were pooled to obtain a Baseline Total. 
Those subjects who did not receive the placebo apparatus presentation 
had significantly lower EMG levels when the EMG scores were adjusted for 
initial baseline differences. Finally, a significant sessions effect
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(EMG reduction over sessions) was found in the analysis of the 
unadjusted data, but when EMG scores were adjusted for initial baseline 
differences no significant session effect was obtained.
TABLE 10
SUMMARY FOR TREND ANALYSIS ON TRIAL 1 THROUGH TRIAL 24 
FOR ADJUSTED EMG SCORES
Group Source df MS F
Total Linear 1 .0069 .001
Within group 1126 7.3106
EA Linear 1 8.5352 1.202
Within group 264 7.5464
ENA Linear 1 . 7703 .240
Within group 264 3.4107
NEA Linear 1 1.9836 .155
Within group 264 13.7474
NENA Linear 1 6.3281 1.607
Within group 264 4.1468
Relationship Between Dependent Measures:
EMG Scores and Questionnaire Items
Correlations were computed between each questionnaire item and 
each subject's EMG scores. Partial correlations were computed between 
the questionnaire items and the EMG scores with the effects of the base­
line removed by a covariate adjustment. Two items in the semantic dif­
ferential were significantly correlated with EMG scores (Table 11).
Item 9d had a significant correlation with EMG levels, jr (48) = -.30, 
jd = .038, and a significant partial correlation, _r (48) = -.31, £  = .035, 
on Session 2. Subjects who perceived the experimenter as more friendly
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TABLE 11
CORRELATIONS AND PARTIAL CORRELATIONS OF MEAN EMG SCORES 
AND QUESTIONNAIRE ITEM RESPONSES
Item r Session 1 Session 2
r Baseline r Session 1 Session 2xy. z
1 How relaxed do you feel now?
not at all relaxed 
completely relaxed
2 How hard did you try to reduce the 
pitch of the tone during feedback 
training?
didn't try at all 
tried very hard
3 How easy was it for you to reduce 
the feedback signal to a low pitch 
and maintain it there?
very easy 
very difficult
4 After talking with the experi­
menter but prior to feedback train­
ing, how successful did you think 
you would be in becoming signifi­
cantly more relaxed as a result of 
the training procedure?
not at all successful 
very successful
5 Do you agree with the following 
statement? a) Psychotherapy helps 
people overcome their problems 
and anxieties?
strongly disagree 
strongly agree
6 New techniques being developed by 
science and psychology are effec­
tive means of reducing stress and 
anxiety so that people can better 
deal with their problems.
strongly agree 
strongly disagree
1134 .0821
-.0084
.0151
-.0747
1112 .0397
.198
-.0119
.0770
0069 .1825
.278
.1703 
. 2153
0035 .0641
.0964
.0279
.0333
0815 -.1131
-.0792
-.2395
-.2442
1082 .1093
.0408
-.0150
-.1097
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TABLE 11— Continued
Item
r
r Baseline rxy. z
Session 1 Session 2 
Session 1 Session 2
7 Before you arrived today to par­
ticipate in this experiment, how 
much did you expect to benefit 
as a result of your participa­
tion? -.0620
benefit very little 
benefit greatly
8 After talking to the experimenter
but prior to feedback training, 
how much did you expect to bene­
fit as a result of your participa­
tion in this experiment? -.1369
benefit very little 
benefit greatly
.0074 .0751
.0869 .1491
-.0443 .0523
.0970 .1829
9 Use the following adjective scales 
to describe your feelings toward and 
impressions of the experimenter.
Check one of the seven spaces between 
each pair of adjectives which best 
describes the experimenter.
a. Cold - warm .0113 .0603
.0810
-.0840
-.1184
b* Incompetent - competent .0173 -.0975 
-. 174
-.2025
-.2773
c. Not confident in the 
experimental procedure - 
confident in the experimental 
procedure
-.1048 -.0859
-.0082
-.1860
-.1556
d. Unfriendly - friendly -.0997 -.1437
-.1054
-.3002*
-.3087*
e.
f.
Unprofessional-professional 
Not concerned about the
-.1080 -.1479
.1021
-.1583
-.1168
subject
concerned about the subject
.1833 .1500 
. 014
-.1298
-.3258*
*£<.05.
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tended to have lower EMG levels. Item 9f also had a significant partial 
correlation on Session 2, £  (48) = -.33, £  = .025. Perception of the 
experimenter as concerned about subject was associated with lower EMG 
levels. There were no other significant partial correlations between 
items and adjusted EMG scores.
Item 10 of the post-session questionnaire revealed that 29 out 
of the 48 subjects had prior knowledge of biofeedback. This may have 
influenced the potency of the expectancy manipulation, therefore sub­
jects were divided according to their response to Item 10 (Aware versus 
Naive). Means and standard deviations were computed for each group 
(Table 12) and a one-way ANOVA was performed on the data (Table 13). 
There were significant differences between the groups for both Session 1 
and Session 2. The subjects who had prior knowledge (i.e., Aware group) 
had significantly lower EMG frontalis levels than those subjects who had 
no prior knowledge (i.e., Naive group) of biofeedback.
TABLE 12
MEANS AND STANDARD DEVIATIONS FOR AWARE AND NAIVE SUBJECTS
Group Count Mean StandardDeviation
Session 1
Aware 19 7.4263 3.9961
Naive 29 5.4276 3.4216
Session 2
Aware 19 7.9158 3.6874
Naive 29 4.1793 1.9888
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TABLE 13
SUMMARY ANOVA FOR SESSION 1 AND SESSION 2 
(AWARE VERSUS NAIVE)
Source df MS F
Session 1
Between Groups 1 45.861 4.671*
Within Groups 46 9.818
Total 47
Session 2
Between Groups 1 160.265 20.738**
Within Groups 46 7.728
Total 47
*£<.0 5
**£<.01
CHAPTER IV
DISCUSSION
This study focused on several variables which were felt to be 
important factors in the performance of an EMG task. The study demon­
strated that the presentation of non-essential apparatus had a negative 
effect on the reduction of EMG frontalis levels. Secondly, although a 
positive expectancy manipulation was perceived by the subjects (self- 
report questionnaire), it had no facilitative effect on reduction of EMG 
levels. The importance of interpersonal qualities was also demonstrated 
as the subjects who perceived the experimenter as friendly and concerned 
tended to have lower EMG levels. Finally, a significant sessions factor 
on the unadjusted EMG scores was obtained while a nonsignificant session 
factor was obtained on the adjusted EMG scores.
It was hypothesized that due to a general acceptance of the 
efficacy of the scientific approach (the incorporation of technological 
devices and apparatus for therapeutic treatment), that the presentation 
of the apparatus would have a facilitative placebo effect in the reduc­
tion of EMG frontalis levels. However, a significant main effect of the 
apparatus variable was found, as the presentation of impressive, nones­
sential apparatus had a negative effect in the reduction of EMG frontalis 
tension.
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A similar negative effect of a placebo variable was also 
reported by Roth (1975). In that study a positive instruction manipula­
tion which was hypothesized to enhance EMG reduction also had an oppo­
site negative effect.
A variety of explanations could account for the obtained results. 
Exposure to the additional apparatus could have increased subject 
arousal, resulting in higher frontalis tension levels which continued 
through Session 1 and Session 2. However, Baseline 1 and Baseline 2 
measures were taken before and after the presentation of the apparatus 
and analysis of the data demonstrated that there was no significant dif­
ference between the baselines. A subsequent ANOVA on Baseline 2 also 
failed to demonstrate any significant differences among treatment condi­
tions following the introduction of the apparatus. Therefore, the pre­
sentation of the apparatus did not appear to increase subject arousal.
Stroebel and Glueck (1973) presented a model which dealt with 
the relationship between expectancy and initial EMG performance. In 
order for a favorable prognostic outcome (i.e., EMG reduction) to occur, 
a balance between a subject's expectations and initial performance was 
necessary. In the present study, if the expectations of the apparatus 
condition subjects were too high in relation to their initial perfor­
mance, the hypothesized outcome would be poor in terms of EMG reduction. 
The ANOVA on the questionnaire items appears to rule out this explana­
tion as no significant main effects for the apparatus groups were found 
on the expectancy items.
A third possible explanation involves the concept of overmotiva­
tion, an explanation entertained by Roth (1975) to describe the negative
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effects of his placebo variable. Orne (1962) stated that subjects 
arrive at experiments with the intention of helping the experimenter 
prove his hypothesis; the subject arrives with a certain level of moti­
vation to do well. The introduction of additional motivating stimuli 
(i.e., additional apparatus) may result in overmotivation and hence a 
deterioration in performance. Aletky and Carlin (1975) demonstrated 
that the use of a placebo jelly in addition to a motivational message 
resulted in a deterioration of performance for male subjects. Pomeranz 
and Krasner (1969) also emphasized that the mechanisms through which 
placebos operate involve the motivational and social reinforcement sys­
tems of the subjects. The situational characteristics of the experiment 
in a quasi-clinical setting along with the introduction of additional 
apparatus may have resulted in overmotivating subjects and subsequently 
interfered with their ability to reduce EMG levels.
A second major result of this study indicated a lack of potency 
of the effect of the expectancy variable on EMG performance. No signif­
icant main effect for the expectancy variable on EMG performance was 
demonstrated even though the effectiveness of the expectancy manipula­
tion tended to be supported by the ANOVA on the questionnaire items 
(i.e., EA and ENA subjects anticipated greater benefit from the task). 
Budzynski (1973) points out that research in the area of biofeedback is 
becoming more difficult due to the exposure of the technique in the 
media. Prior knowledge of biofeedback appears to be an important vari­
able as those subjects who were aware of biofeedback had significantly 
lower EMG levels than those subjects who did not. The nonsignificant 
expectancy effect could be a result of a reduction of the potency of the
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expectancy manipulation due to prior knowledge of the subjects concern­
ing biofeedback. The use of an expectancy placebo manipulation which 
involves positive information about a new technique may be less effec­
tive as the novelty of the technique diminishes and information concern­
ing it becomes available.
The importance of interpersonal factors such as the subject's 
perception of the experimenter (Rosenthal, Fode, Friedman & Vikan-Kline, 
1960; Roth, 1975) was again demonstrated. Subjectively, those subjects 
who perceived the experimenter as more competent and professional tended 
to anticipate more successful outcomes. Those subjects who perceived 
the experimenter as more friendly and more concerned about the subject 
tended to have lower EMG frontalis levels. Although no statements of 
causality can be made, the presence of these qualities along with their 
perception by the subjects appear to be important factors in predicting 
successful outcome in a variety of feedback situations (Fico, 1975; 
Roberts et al., 1973; Roth, 1975).
In comparing the results of the analysis of the unadjusted and 
adjusted data (e.g., adjusted for initial baseline differences) an 
interesting observation was made. A "learning effect" which was indi­
cated by a significant session effect with the unadjusted data (i.e., 
Session 2 EMG levels were significantly lower than Session 1 EMG levels) 
was not present when the EMG scores were adjusted for baseline differ­
ences. A trend analysis on the adjusted data also failed to demonstrate 
any significant linear trend over the twenty-four trials. Although only 
two 12 minute sessions were run, any learning effect which appeared was 
accounted for in terms of baseline differences in subjects.
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The present evidence has important implications in terms of the 
efficacy of biofeedback in reducing EMG levels. Past research has indi­
cated that EMG feedback results in reduction of tension levels over 
training trials (Budzynski et al. , 1973; Kinsman et al., 1975; Roth, 
1975). If as in the present study EMG reduction can be accounted for 
solely by baseline levels, the necessity of the feedback itself is in 
question.
Certain methodological limitations were present in this study 
and will be discussed as they have implications for the generalization 
of the study. A clinical analogue experiment was incorporated which 
used Psychology 101 male students. The validity in generalizing the 
results of this study to a clinical population is at best questionable. 
Another factor which may have influenced the results of this study was 
that the experimenter was not blind to the experimental condition of the 
subject. As Orne (1962) pointed out, the demand characteristics of an 
experimental setting may influence or even account for the outcome of a 
study. Finally, a self-report questionnaire was used as a post hoc mea­
sure to verify subject expectancy independently. The reliability and 
validity of a self-report measure is questionable. The fact that the 
questionnaire was administered following the experimental task also 
could have resulted in a confounding of the effect of variable inter­
vention and the task itself in producing subject expectancy.
This study suggests several directions in designing future bio­
feedback research. Most of the placebo research has concentrated on 
the facilitative effects of placebos rather than on the negative effects 
which were demonstrated in the study. Future research is needed to
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delineate both the facilitative and negative mechanisms which affect 
biofeedback performance. Also needed is a more rigorous a priori veri­
fication of the efficacy of placebo mechanisms (expectancy manipula­
tions) rather than a post-session verification.
Again, the importance of interpersonal factors as a critical 
component in facilitating successful outcomes was demonstrated. This 
conclusion is evidenced not only in the area of biofeedback but also in 
psychotherapy in general. The need for delineation of which therapist 
qualities are associated with more successful outcomes is also evident 
in the area of biofeedback.
The issue of baseline measurement must also be addressed in 
designing future research. The pilot study undertaken in this experi­
ment suggests that a ten minute baseline is more effective for baseline 
stabilization than is a five minute baseline. The use of baselines as a 
covariate adjustment is also indicated as much of the variance in EMG 
performance can be accounted for by initial baseline levels.
Finally, an investigation of the necessity of feedback itself as 
an essential ingredient in producing a learning effect must utilize a 
design which incorporates a session variable over a period of weeks.
This would enable the researcher to look for both within session and 
between session learning effects. The use of a covariate adjustment of 
EMG scores based on baseline levels is also suggested to demonstrate if 
the learning effect is greater than that which can be accounted for by
initial baseline differences.
APPENDIXES
APPENDIX A
PILOT STUDY RESULTS 
Three Minute Sliding Average 
for Baseline Pilot Study
Subject 1 Subject 2 Subject 3 Subject 4
1. 15.8 1. 11.7 1. 9.8 1. 10.7
2. 14. 2 2. 10.0 2. 10.8 2. 9.8
3. 13. 6 3. 9.8 3. 11.0 3. 9.4
4. 11.4 4. 10.1 4. 11.2 4. 9.3
5.- 10.3 5. 9.8 5. 11.3 5. 9.0
6. 9.6 6. 8.9 6. 11.8 6. 8.9
7. 9.5 7. 9.8 7. 11.7 7. 8.9
8. 8.3 8. 10.2 8. 11.5 .8. 8.8
9. 8.3 9. 10.5 9. 11.2 9. 8.4
10. 7.5 10. 9.4 10. 11.3 10. 8.2
11. 7.9 11. 8.5 11. 11.5 11. 8.3
12. 8.0 12. 8.1 12. 11.2 12. 8.7
13. 8.5 13. 8.5 13. 10.8 13. 8.4
14. 8.3 14. 9.5 14. 10.1 14. 10.7
15. 9.3 15. 10.0 15. 10.2 15. 12.2
16. 10.1 16. 9.5 16. 11.3 16. 14.1
17. 9.9 17. 9.0 17. 12.2 17. 13.3
18. 8.3 18. 9.2 18. 12.8 18. 12.7
19. 7.1 19. 10.4 19. 12.3 19. 12.0
20. 7.0 20. 10.5 20. 12.7 20. 11.4
21. 7.6 21. 9.8 21. 12.2 21. 11.6
22. 7.4 22. 8.6 22. 12.1 22. 11.8
23. 7.3 23. 8.8 23. 12.0 23. 11.7
24. 7.4 24. 9.7 24. 12.3 24. 11.8
25. 7.4 25. 11.3 25. 11.7 25. 11.1
26. 7.3 26. 11.6 26. 11.5 26. 10.5
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APPENDIX B - EXPECTANCY MANIPULATION INSTRUCTIONS
You will be participating in a relaxation procedure which incor­
porates the use of biofeedback techniques. This procedure is called 
EMG biofeedbaclc training. Biofeedback training involves the use of 
electrical instrumentation and apparatus which records the level of 
muscle tension in the forehead area. Information concerning the 
level of muscle tension is then made available to the subject in the 
form of an auditory tone. Each subject can use this information to 
learn to voluntarily control the tension level in his forehead area. 
The level of muscle tension in the forehead area has been related to 
such psychophysiological disorders as tension headaches, back pain, 
and chronic anxiety. EMG feedback now offers a means of alleviating 
these disorders. Research has been done in many areas of the country 
in the field of biofeedback, and results indicate that people of both 
sexes and of all ages have been able to demonstrate voluntary con­
trol. Leading researchers in the area have stated that EMG feedback 
offers the best evidence of potential in the treatment of clinical 
disorders. I, myself, in doing research have found that EMG is the 
easiest of the biofeedback modalities to learn to control volun­
tarily. Most subjects have been able to learn to control EMG activ­
ity within one or two sessions and report that it is an effective 
means of learning to relax. In participating in this study I expect 
that you, too, will be able to learn to control the level of tension 
in your forehead area in learning to relax. Hopefully this tech­
nique will also enable you to learn to be aware of situations in 
which you are becoming tense, so that you can learn to relax even 
when you are not attached to the biofeedback apparatus.
Are there any questions?
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APPENDIX C - TASK INSTRUCTIONS
Okay. Now let me explain the feedback training procedure to 
you. This speaker sitting on the table behind you produces a tone 
which represents the degree to which you are tense or anxious. If 
the pitch of the tone goes up that means that you are becoming more 
tense; if the tone drops in pitch it is telling you that your head 
region is becoming more relaxed. I would like you to use this 
information about your muscle tension activity to try and become 
more relaxed. 1 would like you to close your eyes and pay close 
attention to the feelings and sensations in your head region, 
especially when they seem to be related to a decrease in the pitch 
of the tone. Your task is to try and reduce the pitch of the tone 
as much as possible, and maintain it at as low a level as possible, 
thus reducing tension and increasing relaxation. You may experi­
ence some difficulty in getting the pitch to decrease in the begin­
ning. Do not try too hard or this will defeat your goal of deep 
relaxation. Remember, keep your attention focused on the tone—  
don't let your mind wander. In this way you should begin to get a 
feel for how you are able to let go and become more relaxed.
I would like you to remain in the chair for two training ses­
sions of twelve minutes each. At the end of the first session the 
tone will go off, signaling to you that there will be a two minute 
rest period. You may rest during this intermission, and adjust 
your body position, yawn, etc. if you would like. However, at all 
times when the tone is on please remain as quiet and motionless as 
you can. Also, it is important that you do not fall asleep during 
this experiment. So during the rest period, would you please open 
your eyes as a signal to me that you have not fallen asleep.
Are there any questions?
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APPENDIX D - POST-SESSION QUESTIONNAIRE
How relaxed do you feel now? (circle one)
1 2 
not at all 
relaxed
3 4 5 6
completely
relaxed
How hard did you try to 
training?
reduce the pitch of the tone during feedback
1 2 ■ 
didn't try 
at all
3 4 5 6
tried very 
hard
How easy was it for you to reduce the 
pitch and maintain it there?
feedback signal to a low
1 2 
very 
easy
3 4 5 6 
very
difficult
4. After talking with the experimenter but prior to feedback training, 
how successful did you think you would be in becoming significantly
more relaxed as a result of the training procedure?
1 2 3 4 5 6
not at all very
successful successful
Do you agree with the following statements? a) Psychotherapy helps
people overcome their problems and anxieties.
1 2 3 4 5 6
strongly strongly
disagree agree
6. New techniques being developed by science and psychology are effec­
tive means of reducing stress and anxiety so that people can better 
deal with their problems.
1 2 3 4 5 6
strongly strongly
agree disagree
7. Before you arrived today to participate in this experiment, how 
much did you expect to benefit as a result of your participation?
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9.
benefit 
very little
benefit
greatly
8. After talking to the experimenter but prior to feedback training, 
how much did you expect to benefit as a result of your participation 
in this experiment?
1 2 
benefit 
very little
benefit
greatly
Use the following adjective scales to describe your feelings toward 
and impressions of the experimenter. Check one of the seven spaces 
between each pair of adjectives which best describes the experimenter.
a. COLD : : : :
b. INCOMPETENT : :
c. NOT CONFIDENT IN THE
EXPERIMENTAL PROCEDURE
d. UNFRIENDLY I I I
e. UNPROFESSIONAL : :
f. NOT CONCERNED ABOUT
THE SUBJECT * I
WARM
COMPETENT
CONFIDENT IN THE 
EXPERIMENTAL
PROCEDURE
_FRIENDLY
___PROFESSIONAL
CONCERNED ABOUT 
THE SUBJECT
10. Had you ever heard of biofeedback training prior to today? Yes___
No___ If yes, please rate, based on your opinion prior to partici­
pation in this experiment, how effective you thought biofeedback was 
for curing psychological and medical problems?
1 2 3 4 5 6
not at all very
effective effective
11. Did you fall asleep at any time during the experiment? If so, was 
it during the first or second training session? How long were you 
asleep?
12. Briefly describe the strategy you used to reduce the feedback signal 
and keep it at a low level.
13. Before arriving for the experiment today, had you spoken to anyone 
(e.g., classmates) about this experiment? If so, what were you 
told? (It is very important that we know if you had any prior infor­
mation concerning this experiment. No one will be penalized for pro­
viding this information.)
APPENDIX E
EXCLUDED SUBJECTS
Subject - Group Baseline 1 Baseline 2 Session 1 Session 2
1 NEA Mean 6.3 10.7 13.8 15.1
SD 5.2 8.3 5.5 8.4
2 NENA Mean 13.2 14.2 12.0 31.5
SD 3.8 1.2 3.2 2.8
3 NEA Mean 6.3 10.7 13.8 15.1
SD 5.2 8.3 5.5 8.4
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RAW DATA
ENA TREATMENT CONDITION
SUBJECT 1 2 3 4 5 6
BASELINE 1
1. 5.5 8.1 9.0 12.7 3.8 3.2
2. 5.9 7.9 8.9 10.9 5.0 6.2
3. 7.8 9.4 8.7 11.2 3.7 6.1
4. 4.6 9.5 8.6 9.7 4.7 5.7
5. 4.0 8.6 8.8 9.2 5.0 5.0
6. 6.1 8.4 8.6 9.9 4.4 5.9
BASELINE 2
1 . 3.3 10.0 6.2 13.0 4.7 5.3
2. 2.3 9.9 7.8 10.6 3.9 2.9
3. 2.1 9.6 8.7 10.5 2.7 4.0
4. 2.6 9.0 8.4 9.4 2.4 2.5
SESSION 1
1 . 3.4 9.7 8.4 9.0 2.4 3.0
2. 2.7 9.6 8.0 9.3 3.3 2.6
3. 3.5 9.0 8.5 8.5 2.5 2.1
4. 2.7 8.0 8.4 8.2 2.3 3.3
5. 2.8 3.4 8.1 7.5 2.2 2.8
6. 3.2 5.2 8.5 9.0 2.1 1.8
7. 4.5 4.2 8.3 7.5 2.0 2.1
8. 4.3 2.7 8.5 8.7 2.0 1.9
9. 3.6 3.0 8.7 7.0 2.6 2.6
10. 3.6 2.9 7.7 6.9 2.1 4.1
11. 3.6 3.1 7.5 7.4 2.3 3.4
12. 3.9 3.6 6.8 6.5 2.1 4.8
SESSION 2
1. 4.6 4.1 4.9 9.6 3.3 1.8
2. 3.3 3.4 5.0 8.3 2.7 2.0
3. 2.7 3.4 4.5 8.0 2.8 1.9
4. 2.5 3.0 2.4 7.3 3.0 2.5
5. 2.3 3.3 3. 0 7,2 3.4 2.3
6. 2.5 3.3 3.1 7.9 3.4 1.7
7. 3.4 4.2 4.5 7.0 2.7 1.9
8. 4.2 3.4 5.6 7.6 2.5 2.8
9. 3.8 3.7 5.4 6.3 2.2 2.5
10. 3.5 3.7 6.1 7.0 2.4 2.4
11. 3.8 3.4 6.2 8.2 2.2 2.8
12. 3.7 2.8 4.3 7.3 3.1 1.3
ENA TREATMENT CONDITION
SUBJECT 7 8 9 10 11 12
BASELINE 1
1. 7.9 9.1 10.6 11.1 11.4 19.7
2. 7.0 3.7 8.1 9.2 11.6 9.3
3. 7.5 8.5 6.5 8.7 13.1 7.6
4. 6.7 6.3 7.9 10.2 10.4 7.7
5. 6.8 6.4 8.3 11.3 9.6 8.5
6. 6,6 9.0 8.3 11.8 8.2 8.9
BASELINE 2
1. 6.1 2.7 10.5 9.2 13.0 6.9
2. 6.2 5.6 6.2 7.3 12.2 4.9
3. 5.8 2.3 7.3 7.6 6.5 4.8
4. 6.5 1.9 8.0 7.4 6.3 4.7
SESSION 1
1. 7.1 5.2 12.9 6 .0 4.2 6.6
2. 6.4 4.7 7.6 6.1 3.3 5.4
3. 5.4 5.1 6.7 6.2 4.0 5.2
4. 4.6 3.7 8.0 9.7 4.7 6.0
5. 4.6 5.4 5.5 8.2 7.8 4.2
6. 4.7 2.9 4.3 8.0 10.3 5.2
7. 4.8 4.1 6.5 7.8 10.1 5.5
8. 5.5 3.4 6.5 8.7 12.5 5.6
9. 5.2 1.9 4.4 8.0 14.0 5.2
10. 5.3 2.4 4.1 7.9 13.2 4.8
11. 5.7 2.7 6.7 7.6 10.5 4.8
12. 5.3 1.8 6.6 7.5 10.5 4.8
SESSION 2
1. 4.8 4.0 6.8 10.0 11.1 7.4
2. 4.7 3.6 8.1 8.9 10.0 5.8
3. 4.4 3.2 5.1 8.5 11.8 5.1
4. 4.6 3.2 5.6 8.1 12.6 4.4
3. 4.8 3.5 5.1 7.8 13.4 4.3
6. 4.8 3.1 2.7 7.3 15.2 4.3
7. 4. 7 3.2 6.0 7.3 9.4 3.8
8. 4.6 2.5 4.1 7.1 10.1 6.2
9. 4.6 2.4 2.1 6.9 8.5 5.1
10. 4.3 2.5 2.1 6.8 12.3 5.1
11. 4.6 2.7 4.8 6.9 7.2 4.8
12. . 4.3 2.4 4.7 6.9 10.2 4.8
NEA TREATMENT CONDITION
SUBJECT 1 2 3 4 5 6
BASELINE 1
1. 6.5 11.4 4.7 13.1 6. 6 5.8o
c . . 5.7 10.3 4.0 8.8 5.8 7.4
3. 6.4 11.7 4.2 7.2 4.2 7.5
4. 6.6 10.8 4.3 8.0 5.1 5.9
5. 6.5 10.5 4.9 7.0 5.1 5.4
6. 4.8 11.1 5.3 8.9 5.2 7.4
BASELINE 2
1. 6.1 15.1 5.7 8.3 5.8 6.6
2. 4.0 20.1 5.2 6.9 4.6 5.3
3. 3.7 18.1 5.7 6. 6 4.3 4.1
4. 3.8 15.4 8.1 5.3 4.5 3.2
SESSION 1
1. 6.3 19.9 6.0 4.5 4.9 8.3
2. 4.1 23.1 5.8 2.3 4.2 5.3
3. 3.9 19.5 6.7 2.7 3.8 4.5
4. 4.6 18.3 6.5 3.0 3.4 5.7
5. 4.8 14.2 5.9 2.5 3.1 4.3
6. 4.5 15.3 7.2 3.7 3.2 4.4
7. 3.4 14.9 8.5 4.3 3.6 4.3
8. 3.2 15.8 8.2 2.5 3.1 3.9
9. 3.7 17 .8 8.7 2.7 3.4 3.1
10. 4.2 17.4 9.1 2.5 3.2 3.3
11. 3.7 17.6 9.3 3.5 4.2 3.5
12. 3.6 17.1 9.1 3.0 4.1 3.1
SESSION 2
1. 3.6 21.8 6.0 3.9 2.6 4.6
2. 2.6 22.0 4.4 4.8 3.2 3.8
3. 2.4 17.1 5.2 4.5 3.9 3.5
4. 2.6 13.8 6. 4 4.5 3.9 3.0
5. 2.6 14.6 8.0 4.3 3.9 3.6
6. 2.6 13.6 7.5 4.2 4.0 3.3
7. 2.1 12.3 9.0 5.5 3.8 3.2
8. 1.7 16.1 9.5 6.9 3.4 2.8
9. 1.6 13.0 9.7 5.2 3.0 2.7
10. 7.6 12.1 7.4 6.0 3.0 2.0
11. 10.3 13.6 9.2 5.3 3.1 2.2
12. 7.0 15.0 10.2 5.4 3.2 3.1
NEA TREATMENT CONDITION
SUBJECT 7 8 9 10 11 12
BASELINE 1
1. 10.4 7.3 5.9 9.6 16.4 3.3
2. 11.1 6.4 6.6 8.1 7.3 2.3
3. 9.5 5.9 6.2 6.4 6.4 3.3
4. 13.4 5.2 7.2 4.8 6.7 4.0
5. 9.5 5.1 7.1 8.4 5.9 2.9
6. 12.1 5.3 7.2 8.3 5.5 4.4
BASELINE 2
1. 6.5 8.8 7.3 9.3 8.3 6.7
2. 6.6 8.5 6.3 8.5 13.9 6.3
3. 5.4 8.2 6.9 6.2 11.8 6.3
4. 4.9 8.5 7.8 5.0 6.6 5.8
SESSION 1
1. 5.9 10.8 6.3 5.8 10.2 6.5
2. 6.9 10.1 10.2 5.3 9.6 6.6
3. 6. 6 9.1 10.7 5.5 9.5 6.6
4. 6.6 7.7 10.3 4.4 7.4 5.3
5. 5.8 8.2 10.3 3.5 3.5 4.3
6. 5.6 8.7 9.0 4.8 4.2 1.4
7. 5.9 10.8 8.9 3.9 4.8 1.2
8. 5.7 9.9 9.4 4.6 4.7 1.5
9. 5.0 13.2 9.4 3.5 5.9 1.1
10. 4.4 16.1 9.3 2.1 5.7 1.0
11 . 4.5 17.9 9.3 4.0 6.9 .9
12. 3.7 16.7 9.5 4.7 5.0 .5
SESSION 2
1 . 2.4 17.2 6.9 8.1 9.6 1.1
2. 1.6 16.7 6. 6 5.6 10.0 1.1
3. 1.9 13.1 7.4 5.3 5.4 .7
4. 2.0 14.1 7.5 4.6 5.7 .9
3. 1.4 15.5 7.5 4.4 4.5 1.1
6. 1.3 17.1 7.3 4.4 3.1 .8
7. 1.0 12.7 7.6 4.8 2.5 1.0
8. 2.1 13.3 7.5 6.5 2.3 .9
9. 4.2 12.4 7.3 7.6 4.8 .8
10. 8.9 11.9 7.9 8.2 5.3 .5
11. 2.6 12.4 7.8 10.1 3.2 .3
12. 2.7 11. 7 8.3 9.2 4.7 .2hO
L
D
L
n
C
O
^
O
O
C
O
H
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EA TREATMENT CONDITION
SUBJECT 1 2 3 4 5 6
BASELINE 1
1 . 5.5 5.0 11.1 6.5 7.9 16.4
2. 5.3 4.7 11.4 7.4 7.1 14.2
3. 5.3 6.1 10.0 8.2 6.5 14.4
4. 5.6 5.6 11.3 7.8 5.1 7.9
5. 5.3 7.5 10.7 7.1 5.0 8.9
6. 5.2 4.8 8.7 6.9 5.1 8.4
BASELINE 2
1. 9.9 6.4 11.3 11.7 5.2 10.6
2. 11.0 4.4 11.8 8.5 3.5 8.0
3. 9.4 4.6 9.3 7.0 2.4 10.4
4. 9.4 4.1 9.2 12.3 1.7 13.5
SESSION 1
1. 11.3 6.9 11.3 12.4 4.0 12.9
2. 11.2 4.9 10.9 11.0 4.0 13.6
3. 13.3 4.8 10.3 8.8 3.4 15.6
4. 11.1 4.8 10.5 10.2 3.3 14.8
5. 10.1 3.5 9.1 8.4 4.4 14.6
6. 5.5 4.3 10.2 7.5 1.6 16.3
7. 6.4 4.1 9.1 6.4 .9 13.6
8. 8.3 3.6 10.1 5.8 1.9 13.0
9. 12.0 3.3 10.5 10.5 2.4 13.7
10. 8.3 3.2 9. 7 9.7 1.0 11.7
11. 4.8 3.6 9.9 9.0 1.7 14.4
12. 5.6 3.8 9.1 9.0 1.4 12.7
SESSION 2
1. 7.0 8.6 8.9 12.6 2.6 9.4
2. 8.8 8.2 8.3 9.7 1.6 12.8
3. 10.4 8.0 8.2 8.0 1.4 9.4
4. 10.3 7.4 9.3 9.0 1.0 9.4
5. 13.6 8.5 9.5 6.1 1.6 9.3
6. 13.9 7.9 9.4 5.6 1.3 9.5
7 . 13.0 7.8 9.1 6.1 .9 8.7
8. 14.0 8.0 9.0 5.6 1.8 8.3
9. 14.0 7.8 9.3 7.0 .8 8.8
10. 11.7 9.0 11.4 7.3 1.0 8.0
11. 10.6 7.7 7.7 4.0 1.1 8.5
12. 9.9 7.4 8.0 6.5 .9 8.3
EA TREATMENT CONDITION
SUBJECT 7 8 9 10 11 12
BASELINE 1
1. 4.7 6.4 3.3 12.8 11.0 4.6
2. 4.3 8.2 3.9 11.8 11.4 5.8
3. 5.0 5.7 5.1 13.0 8.7 6.1
4. 5.5 5.8 5.0 12.7 8.4 5.8
5. 6.5 6.7 4.7 12.4 11.0 7.5
6. 3.8 6.9 4.9 17.2 7.7 6.7
BASELINE 2
1. 4.7 5.0 4.9 9.4 10.5 6.5
2. 5.3 5.9 4.1 9.6 10.6 4.4
3. 6.2 4.1 5.5 9.1 9.2 5.1
4. 5.1 5.1 5.1 10.0 9.5 4.8
SESSION 1
1. 7.1 6.9 6.3 12.7 16.3 4.6
2. 5.6 6.1 5.5 10.2 13.0 4.4
3. 4.8 5.8 5.3 8.5 12.8 4.0
4. 4.2 5.0 4.0 8.5 11.6 4.6
5. 4.5 6.5 3.4 8.2 11.7 4.4
6. 3.7 5.8 3.5 10.9 11.2 3.6
7. 3.4 4.0 4.2 9.4 13.0 3.5
8. 3.8 4.9 3„8 9.4 11.6 2.9
9. 2.9 5.1 5.0 7.4 9.5 2.6
10. 3.9 3.5 4.8 7.3 8.6 3.4
11. 3.8 4.0 4.5 7.4 8.9 3.0
12. 3.4 2.4 4.9 7.7 8.4 2.9
SESSION 2
1. 1 16.0 3.8 3.6 7.6 8.9 3.1
2. 11.0 2.9 3.7 7.5 9.1 3.1
3. 6.6 2.5 3.2 7.4 8.5 3.0
4. 5.8 3.0 2.0 7.4 10.4 2.9
5. 4.8 2.5 1.5 7.8 11.4 3.8
6. 6.2 2.8 2.9 4.2 10.4 3.1
7. 4.3 3.8 2.6 3.7 9.8 2.8
8. 7.7 3.9 2.4 4.1 8.6 3.7
9. 8.7 3.8 2.3 4.5 10.8 3.9
10. 9.0 2.6 1.8 4.9 14.2 3.2
11. 9.5 3.0 1.6 4.4 8.5 3.5
12. 9.0 3.4 1.6 5.3 10.4 3.7
NENA TREATMENT CONDITION
SUBJECT 1 2 3 4 5 6
BASELINE 1
1. 4.5 7.1 14.7 4.6 12.2 10.7
2. 5.2 5.6 9.4 5.3 8.1 9.4
3. 5.1 6.5 11.0 8.5 8.1 8.6
4. 5.2 5.7 11.4 7.0 9.7 8.9
5. 5.4 4.5 10.0 5.8 13.4 10.8
6. 5.2 5.0 11.7 6.2 4.7 10.6
BASELINE 2
1. 4.7 6.4 11.4 6.8 4.9 6.8
2. 3.8 6.2 10.4 7.1 6.8 5.1
3. 4.6 5.4 8.7 6.6 7.9 4.4
4. 4.9 5.7 12.1 7.4 5.9 4.8
SESSION 1
1. 4.8 4.1 7.7 8.2 6.2 3.5
2. 5.0 4.5 7.1 4.8 6.4 3.3
3. 4.9 5.0 7.5 4.4 6.2 2.9
4. 4.9 3.2 7.1 6.2 6.8 4.0
5. 5.1 4.0 8.1 5.1 4.9 3.1
6. 5.0 3.8 7.1 4.8 5.6 3.4
7. 5.9 4.6 6.9 6.4 6.0 4.5
8. 5.9 3.7 7.2 7.3 4.4 4.5
9. 5.8 4.9 6.1 7.5 5.1 3.5
10. 5.8 4.0 5.7 7.5 6.7 3.3
11. 5.6 3.7 6.1 6.3 5.9 2.1
12. 5.7 4.1 5.6 6.2 4.0 2.6
SESSION 2
1. 2.7 5.5 6.1 5.5 4.6 3.6
2. 2.6 4.3 6. 6 6.3 4.7 2.5
3. 2.9 4.1 6.2 6.2 4.3 3.8
4. 3.2 3.0 4.9 6.1 4.3 5.6
5. 3.5 3.4 5.1 6.3 4.1 6.1
6. 3.7 3.8 6.7 6.5 3.4 10.9
7. 4.5 4.8 6. 4 7.0 2.1 13.6
8. 4.4 3.5 5.5 6.5 1.8 10.8
9. 4.4 3.5 5.9 7.5 2.7 11.8
10. 5.4 3.7 8.7 7.0 2.8 9.8
11. 5.2 3.4 7.4 6.4 2.3 9.4
12. 4.6 3.9 6.3 6.5 1.3 8.6
NENA TREATMENT CONDITION
SUBJECT 7 8 9 10 11 12
BASELINE 1
1. 5.2 7.0 3.5 12.1 4.0 6.1
2. 4.4 5.1 2.8 11.0 4.0 5.9
3. 4.6 5.2 3.3 11.6 4.6 6.1
4. 4.5 5.8 3.3 11.6 5.1 7.0
5. 4.6 7.0 3.0 13.6 3.5 7.0
6• 4.3 6.8 3.5 12.6 4.3 5.2
BASELINE 2
1. 9.1 3.6 4.6 11.2 4.5 4.0
2. 6.1 3.4 4.8 10.2 4.2 3.0
3. 6.0 3.3 3.6 9.6 4.8 5.0
4. 4.5 3.8 3. 7 12.2 4.8 4.9
SESSION 1
1. 4.4 3.5 5.1 10.3 5.0 5.6
2. 4.1 3.9 4.5 12.4 2.5 4.5
3. 4.1 3.7 4.0 14.1 3.4 4.9
4. 3.9 4.2 3.5 14.2 3.6 4.1
5. 4.7 3.8 3.4 12.4 4.7 5.4
6, 4.1 3.9 3.1 12.8 3.1 4.2
7. ' 3.4 3.7 3.3 12.5 3.6 4.7
8. 4.1 3.7 3.7 11.2 4.0 5.5
9. 4.5 3.7 3.8 11.4 5.4 4.9
10. 3.2 3.0 4.0 10.7 1.8 4.8
11. 3.0 2.8 3.9 10.8 1.2 4.6
12. 4.1 2.6 3.8 11.0 1.7 5.3
SESSION 2
1. 5.3 1.7 2.9 9.9 2.1 5.0
2. 4.8 1.6 2.4 11.5 3.5 5.2
3. 5.0 2.2 2.2 11.4 1.3 3.6
4. 3.4 1.7 2.5 12.2 1.8 4.4
5. 3.0 2.2 1.8 13.0 1.6 4.8
6. 2.9 1.6 1.7 13.5 .9 5.0
7. 3.9 1.9 1.5 10.8 .8 3.9
8. 3.1 1.6 1.7 12.2 2.6 5.2
9. 4.3 1.5 2.0 11.4 2.0 5.8
10. 3.6 1.5 2.1 12.2 2.3 3.8
11. 3.5 2.9 2.1 12.5 2.3 4.1
12. 4.4 2.9 1.8 11.1 2.4 5.6
A
